SCHEMBL90603

SCHEMBL90603

NC1(c2cccnc2)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30397815 0.98
SCHEMBL20773318 0.98
SCHEMBL18769472 0.96 AKT1 (0.43)
Hydrochloric Acid SCHEMBL18742641 0.94 AKT1 (0.42)
Hydrochloric Acid SCHEMBL29857983 0.94 AKT1 (0.42)
SCHEMBL11971740 0.92 ALDH1A1 (0.41)
Hydrochloric Acid SCHEMBL23778490 0.90 ALDH1A1 (0.39)
SCHEMBL31158371 0.83 OPRM1 (0.41)
SCHEMBL23647413 0.83 OPRM1 (0.41)
SCHEMBL29218693 0.82 KDM1A (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148971-A1 DEUBIQUITINASE INHIBITORS Pharmakea, Inc. (US) 2017-04-05 EP disclosed
US-20170088520-A1 DEUBIQUITINASE INHIBITORS PHARMAKEA, INC. 2017-03-30 US disclosed
WO-2015187427-A1 DEUBIQUITINASE INHIBITORS PHARMAKEA, INC. (US) 2015-12-10 WO disclosed
US-8129411-B2 Organic compounds NOVARTIS AG (CH) 2012-03-06 US disclosed
US-8129411-B2 Organic compounds NOVARTIS AG (CH) 2012-03-06 US disclosed
EP-2420491-A1 3 , 5-substitued piperidine compounds as renin inhibitors Novartis AG (CH) 2012-02-22 EP disclosed
US-20090192148-A1 Organic Compounds NOVARTIS AG (CH) 2009-07-30 US disclosed
US-20090192148-A1 Organic Compounds NOVARTIS AG (CH) 2009-07-30 US disclosed